By: Anni Schleicher, Nutrition Insight
Evolva’s Veri-te resveratrol fights cognitive decline in post-menopausal women
06 Apr 2020 — Daily supplementation with Evolva’s Veri-te resveratrol ingredient can improve cognitive performance and reduce the decline in cerebrovascular responsiveness (CVR) of postmenopausal women. This is according to the first findings of the Resveratrol Supporting Healthy Aging in Women (RESHAW) clinical study, which makes for the largest, longest-running study of its kind with resveratrol. The newly Nutrients-published study highlights that regular consumption of resveratrol can support the cause against cognitive decline, considering that independent of life expectancy, dementia mortality rates in global women in 2016 were almost twice that of men.
“The RESHAW clinical study provides evidence that supplementation with Veri-te resveratrol should be a key strategy for the design and delivery of effective supplements as women age. This is to improve overall well-being post-menopause,” says Clare Panchoo, Vice President of Health Ingredients, Evolva.